Skip to main content

Table 2 Human medicine: pharmaceuticals for cancer

From: Consumer-perceived risks and choices about pharmaceuticals in the environment: a cross-sectional study

 

Alocyl

Botorex

Cetozol

Relative age of drug

Newer

Older (Newer)

Older

Per cent of patients that are cancer-free (i.e., cured) following treatment

90%

70%

50%

Per cent decline in the reproductive rate of Rainbow Trout

40%

20%

0%

  1. Note. Botorex was older when compared to Alocyl, but newer when compared to Cetozol.